Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis

Nephrology Dialysis Transplantation

Volumn 19, Issue 6, 2004, Pages 1467-1473

  Tamano, Mariko ^a,c   Ohi, Hiroyuki ^a   Sudo, Sukemasa ^b   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kasukabe Kisen Hospital   (Japan)

^c NONE   (Japan)

Author keywords

Complement receptor type 1; CR1; Dialysis membrane; Haemodialysis; Polymorphism

Indexed keywords

ADENINE; BIOMATERIAL; CELLULOSE; COMPLEMENT COMPONENT C3B RECEPTOR; CYTOSINE; GUANINE; NUCLEOTIDE; POLYACRYLONITRILE; POLYSULFONE; TRYPSIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; ERYTHROCYTE; GENETIC POLYMORPHISM; HEMODIALYSIS; HUMAN; INCUBATION TIME; JAPAN; MAJOR CLINICAL STUDY; PATIENT SELECTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS;

AGED; COMPLEMENT C3; COMPLEMENT C5; ENDOPEPTIDASES; HUMANS; MEMBRANES, ARTIFICIAL; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT; RENAL DIALYSIS;

EID: 2942707878     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh184     Document Type: Article

References (25)

1. Krych-Goldberg M, Atkinson JP. Structure-function relationships of complement receptor type 1. Immunol Rev 2001; 180: 112-122
2. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leucocyte, B lymphocyte and monocyte. J Exp Med 1980; 152: 20-30
3. Appay MD, Kazatchkine MD, Levi-Strauss M, Hinglais N, Bariety J. Expression of CR1(CD35) mRNA in podocytes from adult and fetal human kidneys. Kidney Int 1990; 38: 289-293
4. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J Immunol 1999; 163: 5056-5063
5. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jenseius JC, Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 2000; 192: 1797-1808
6. Schifferli JA, Ng YC, Esteicher J, Walport MJ. The clearance of tetanus toxoid/anti tetanus toxoid immune complexes from the circulation of humans: complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol 1988; 140: 899-904
7. Medof ME, Prince GM, Mold C. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of beta 1H and is accompanied by generation of C3c. Proc Natl Acad Sci USA 1982; 79: 5047-5051
8. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986; 164: 50-59
9. Wilson JG, Wong WW, Schur PH, Fearon DT. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 1982; 307: 981-986
10. Cohen JH, Geffriaud C, Caudwell V, Kazatchkine MD. Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals. AIDS 1989; 3: 397-399
11. Ross GD, Yount WJ, Walport MJ et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol 1985: 135: 2005-2014
12. Kumar A, Malaviya AN, Sinha S, Khandekar PS, Banerjee K, Srivastava LM. C3b receptor(CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon. Immunol Res 1994; 13: 61-71
13. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999; 55: 1081-1090
14. Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 1993; 3: 1541-1554
15. Cornillet P, Philbert F, Kazatchkine MD, Cohen JH. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J Immunol Methods 1991; 136: 193-197
16. Xiang L, Rundles JR, Hamilton DR, Wilson JG. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 1999; 163: 4939-4945
17. Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med 1988: 168: 1699-1717
18. Pascual M, Danielsson C, Steiger G, Schifferli JA. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. Eur J Immunol 1994; 24: 702-708
19. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998; 87: 176-183
20. Lach-Trifilieff E, Marfurt J, Schwarz S, Sadallah S, Schifferli JA. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients. J Immunol 1999; 162: 7549-7554
21. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993; 44: 484-494
22. Heidland A, Hörl WH, Heller N, Heine H, Neumann S, Heidbreder E. Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Kidney Int 1983; 24 [Suppl 161: S27-S36
23. Miot S, Marfurt J, Lack-Trifilieff E et al. The mechanism of loss of CR1 during maturation of erythrocytes is different between factor I deficient patients and healthy donors. Blood Cells Mol Dis 2002; 29: 200-212
24. Ohi H, Tamano M, Sudo S, Okada N. Recombinant erythropoietin therapy increases erythrocyte expression of complement regulatory proteins. Am J Kidney, Dis 2003; 41: 179-185
25. Hebert LA, Birmingham DJ, Dillon JJ, Cosio FG, Shen XP. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). J Am Soc Nephrol 1994; 4: 1786-1791